PACAP-27 vs GLP-1

Head-to-head comparison of PACAP-27 (Pituitary Adenylate Cyclase-Activating Polypeptide-27) and GLP-1 (Glucagon-like peptide-1 (7-36 amide)) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyPACAP-27GLP-1
CategoryDiabetes & MetabolicDiabetes & Metabolic
Full NamePituitary Adenylate Cyclase-Activating Polypeptide-27Glucagon-like peptide-1 (7-36 amide)
Molecular Weight3158 Da3297 Da
Half-Lifeminutes1-2 minutes
Amino Acids2730
Typical DoseResearch-only: 0.1-1 nmol/kgResearch-only: 0.1-1.0 pmol/kg/min
RouteIntraperitoneal/SubcutaneousIntravenous/Subcutaneous
Purity≥98%≥98%
Studies Count2201200
Research StatusPre-clinicalPre-clinical

PACAP-27 Benefits

  • anti-apoptotic signaling
  • insulin secretagogue effect
  • reduced ER stress
  • islet cytoprotection

GLP-1 Benefits

  • beta-cell protection
  • improved insulin secretion
  • slower gastric emptying
  • lower postprandial glucose

PACAP-27 Dosing

0.1-1 nmol/kg in animal studies|10-100 nM in vitro|research-only intermittent dosing

GLP-1 Dosing

0.1-1.0 pmol/kg/min IV infusion in research|0.5-10 nM in vitro|continuous delivery in animal studies

PACAP-27 Side Effects

  • flushing
  • hypotension at high exposure
  • headache

GLP-1 Side Effects

  • nausea at pharmacologic exposure
  • tachyphylaxis with continuous exposure
  • headache

Research Overview

PACAP-27

PACAP-27 has been repeatedly shown to support beta-cell survival through cAMP/PKA and related pathways. In experimental models it mitigates cytokine damage, preserves insulin content, and helps maintain islet viability.

GLP-1

Native GLP-1 has a very short half-life because of rapid DPP-4 cleavage, so it is mainly used as a mechanistic research peptide. Across animal and cellular studies it reduces beta-cell apoptosis, improves insulin gene expression, and enhances islet resilience.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

PACAP-27 stacks with:

GLP-1 analogsDPP-4 inhibitorsdiet and exercise

GLP-1 stacks with:

DPP-4 inhibitorsSGLT2 inhibitorsdiet and exercise
neuropeptidebeta-cell protectioncAMP signalingincretinbeta-cell survivalDPP-4 substrate